Vimarsana
Biggest News Aggregation in the World

Page 45 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

Yield10 Bioscience : Camelina Seed Oil, a Sustainable Source of Biofuel - Vimarsana News

Yield10 Bioscience : Camelina Seed Oil, a Sustainable Source of Biofuel

Dr. Oliver Peoples, the CEO of Yield10 Bioscience explains the use of Camelina seed oil as a potential source of biofuel and discusses its implications in the transportation industry in a... | February 15, 2022

Alligator Bioscience AB: Year End report January-December 2021 - Vimarsana News

Alligator Bioscience AB: Year End report January-December 2021

STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving Forward "During the fourth quarter 2021, Alligator reached several key milestones in our pre-clinical

Ucello Therapeutics Gets $25M - socaltech.com - Vimarsana News

Ucello Therapeutics Gets $25M - socaltech.com

San Diego- and Chengdu, China-based Ucello Therapeutics, a biotechnology startup which says it is developing universal CAR-T therapies, has raised $25M in a Series A financing round. The company said the funding was led by Matrix Partners Chin

SK Bioscience to develop COVID-19 Omicron-specific vaccine - Vimarsana News

SK Bioscience to develop COVID-19 Omicron-specific vaccine

Seoul [South Korea], February 9 (ANI/Global Economic): As the Omicron COVID-19 variant, which is now the most dominant strain in the world, rapidly spread in Korea, SK Bioscience also started developing Omicron-specific vaccines.

Arix Bioscience PLC: Total Voting Rights - Vimarsana News

Arix Bioscience PLC: Total Voting Rights

DJ Total Voting Rights Arix Bioscience PLC (ARIX) Total Voting Rights 08-Feb-2022 / 07:20 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible